Research Study

Augmentation Versus Switch: Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With Treatment Resistant Depression (ASCERTAIN-TRD)
Principal Investigator 
Fidel Vila-Rodriguez

Overview

Body Locations and Systems 
Depression
Disorders and Conditions 
ClinicalTrials.gov# 
NCT02977299
Status 
Recruiting
Study Start/End 
Jan 25, 2018 to Jan 31, 2022
Locations 
UBC Hospital
Name/Title 
Afifa Humaira or Sahaah Malik, Study Coordinators
Phone 
604-822-7308
Email Address 
ninet.lab@ubc.ca
Purpose of Study 

The purpose of this study is to compare the effectiveness of three different treatment options for those dealing with treatment-resistant depression.  The three different treatment options are: (1) adding aripiprazole to their current treatment, (2) adding repetitive transcranial magnetic stimulation (rTMS) to their current treatment, and (3) switching their current treatment to Venlafaxine.

recruitment poster

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.